Influenza Flu Articles & Analysis
5 news found
Predictions of which influenza strains will be circulating each year are made more than six months before the onset of flu season—and even if projections are accurate, unexpected strains can and do arise, rendering that year’s vaccine minimally effective. ...
EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza strains—including all flu pandemics. Seasonal flu causes 50,000–250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as ...
Though the SARS-CoV-2 virus (which causes COVID-19) is straining global resources, its rate of mortality is actually far lower than that seen in cases of exposure to some other influenza viruses. The Spanish flu pandemic affected a staggering number of global citizens, with more than 50 million deaths documented worldwide. ...
EnGen Bio is an early stage biotechnology company pioneering a new approach to preventing and treating influenza, with the goal of an effective, easy-to-manufacture, shelf-stable universal flu vaccine that should confer long-term immunity to all Type A influenza strains—including all flu pandemics. Seasonal ...
Thermo Fisher Scientific announces CE-marking of its TaqPath COVID-19, Flu A/B, RSV Combo Kit for the in vitro diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV) A/B infections. Using the new kit, laboratories can now can run a single test for SARS-CoV-2, influenza (flu) A/B, and RSV to detect and ...